Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Prostate Health Market, and What Factors Will Drive It?

The size of the prostate health market has seen a significant growth in the past few years. The market, which is predicted to be worth $34.07 billion in 2024, is expected to rise to $37.23 billion in 2025, showcasing a compound annual growth rate (CAGR) of 9.3%. Factors like an aging demographic, expanded PSA screening, heightened awareness campaigns, advances in hormone therapy, and growing occurrence rates have contributed to this historical growth.

In the coming years, the prostate health market is forecasted to witness robust growth. By 2029, the market is projected to reach a worth of $52.81 billion, rising at a compound annual growth rate (CAGR) of 9.1%. The anticipated growth during this forecast period will likely be due to increased use of precision medicine, advancements in AI-based diagnosis, expansion of targeted radiation therapy, rising demand for less invasive treatment methods, and better genetic profiling for evaluating risks. Significant trends for this forecast period encompass AI-based risk evaluations, breakthroughs in liquid biopsy, new-generation radiotheranostics, progress in immunotherapy, and real-time biomarker supervision.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21265&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Prostate Health Market?

The escalating occurrence of prostate cancer is anticipated to stimulate the expansion of the prostate health market in the future. This form of cancer transpires when the cells in the prostate gland multiply uncontrollably, usually displaying as adenocarcinomas, the most prevalent form of this disease in males. The increasing occurrence of prostate cancer primarily stems from the growing ageing population, expanded screening measures, and lifestyle influences such as obesity and physical inactivity. Keeping good prostate health is vital for the prevention, early identification and control of prostate cancer. For example, the American Cancer Society (ACS), a charity based in the U.S., predicted that in January 2023, close to 288,300 new cases of prostate cancer would be recorded in the U.S., resulting in approximately 34,700 death cases. Hence, the escalating incidence of prostate cancer will foster the expansion of the prostate health market.

Which Key Market Segments Comprise the Prostate Health Market and Drive Its Revenue Growth?

The prostate healthmarket covered in this report is segmented –

1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis

2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments

3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels

Subsegments:

1) By Prostate Cancer: Localized Prostate Cancer; Metastatic Prostate Cancer

2) By Benign Prostate Hyperplasia: Mild BPH; Moderate BPH; Severe BPH

3) By Prostatitis: Acute Bacterial Prostatitis; Chronic Bacterial Prostatitis; Chronic Prostatitis (Non-Bacterial)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21265&type=smp

Which Areas Are Leading Regions in the Prostate Health Market Expansion Across the Globe?

North America was the largest region in the prostate health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theProstate Health Market Direction?

Major market players in the prostate health industry are leveraging advanced technology, such as AI-enhanced risk evaluation, to maintain their competitive advantage. This type of risk assessment employs artificial intelligence and machine learning models to interpret data and foresee potential risks, thus aiding in the process of making well-informed decisions and optimizing outcomes. A relevant example would be the alliance in September 2024 between Nanostics Inc., a Canadian clinical-stage biotechnology firm, and Protean BioDiagnostics, an American biotech company. The collaboration resulted in the creation of CDX Prostate, a diagnostic device engineered to support men at risk of severe prostate cancer. The tool utilizes a combination of biological data, clinical information, and AI-driven learning algorithms to calculate a risk grade for advanced prostate cancer. With its high-end machine learning algorithms in play, CDX Prostate offers more precise risk grades than conventional methods by analyzing diverse biological and clinical facts. This test is significant for healthcare experts and patients to make knowledge-based decisions on whether to perform a biopsy following increased prostate-specific antigen (PSA) test outcomes or anomalous digital rectal examination (DRE).

View the full report here:

https://www.thebusinessresearchcompany.com/report/prostate-health-global-market-report

How Is the Prostate Health Market Conceptually Defined?

Prostate health refers to the overall well-being and proper functioning of the prostate gland, a small organ in men that produces seminal fluid. Maintaining prostate health is essential for urinary function, reproductive health, and preventing conditions such as prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer. Factors influencing prostate health include age, genetics, diet, lifestyle, and regular medical screenings.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21265

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model